Literature DB >> 19091868

Genome comparison of a nonpathogenic myxoma virus field strain with its ancestor, the virulent Lausanne strain.

Mónica Morales1, Miguel A Ramírez, María J Cano, Mario Párraga, Joaquín Castilla, Luis I Pérez-Ordoyo, Juan M Torres, Juan Bárcena.   

Abstract

One of the best-studied examples of host-virus coevolution is the release of myxoma virus (MV) for biological control of European rabbits in Australia and Europe. To investigate the genetic basis of MV adaptation to its new host, we sequenced the genome of 6918, an attenuated Spanish field strain, and compared it with that of Lausanne, the strain originally released in Europe in 1952. Although isolated 43 years apart, the genomes were highly conserved (99.95% identical). Only 32 of the 159 MV predicted proteins revealed amino acid changes. Four genes (M009L, M036L, M135R, and M148R) in 6918 were disrupted by frameshift mutations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19091868      PMCID: PMC2643724          DOI: 10.1128/JVI.02189-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

1.  Cloning and molecular characterization of the myxoma virus genome.

Authors:  R J Russell; S J Robbins
Journal:  Virology       Date:  1989-05       Impact factor: 3.616

2.  Comparison of the genome DNA sequences of Bangladesh-1975 and India-1967 variola viruses.

Authors:  S N Shchelkunov; R F Massung; J J Esposito
Journal:  Virus Res       Date:  1995-04       Impact factor: 3.303

3.  Comparative genetic analysis of genomic DNA sequences of two human isolates of Tanapox virus.

Authors:  Steven H Nazarian; John W Barrett; A Michael Frace; Melissa Olsen-Rasmussen; Marina Khristova; Mae Shaban; Sarah Neering; Yu Li; Inger K Damon; Joseph J Esposito; Karim Essani; Grant McFadden
Journal:  Virus Res       Date:  2007-06-14       Impact factor: 3.303

4.  Two types of deletions in orthopoxvirus genomes.

Authors:  S N Shchelkunov; A V Totmenin
Journal:  Virus Genes       Date:  1995-02       Impact factor: 2.332

5.  Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity.

Authors:  J A Symons; A Alcamí; G L Smith
Journal:  Cell       Date:  1995-05-19       Impact factor: 41.582

6.  Evidence for recent genetic variation in monkeypox viruses.

Authors:  N J Douglass; M Richardson; K R Dumbell
Journal:  J Gen Virol       Date:  1994-06       Impact factor: 3.891

7.  Genomic sequence of chorioallantois vaccinia virus Ankara, the ancestor of modified vaccinia virus Ankara.

Authors:  Christine Meisinger-Henschel; Michaela Schmidt; Susanne Lukassen; Burkhard Linke; Lutz Krause; Sebastian Konietzny; Alexander Goesmann; Paul Howley; Paul Chaplin; Mark Suter; Jürgen Hausmann
Journal:  J Gen Virol       Date:  2007-12       Impact factor: 3.891

8.  Delay of vaccinia virus-induced apoptosis in nonpermissive Chinese hamster ovary cells by the cowpox virus CHOhr and adenovirus E1B 19K genes.

Authors:  B S Ink; C S Gilbert; G I Evan
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

9.  Myxoma virus and Shope fibroma virus encode dual-specificity tyrosine/serine phosphatases which are essential for virus viability.

Authors:  K Mossman; H Ostergaard; C Upton; G McFadden
Journal:  Virology       Date:  1995-01-10       Impact factor: 3.616

10.  Vaccinia virus B18R gene encodes a type I interferon-binding protein that blocks interferon alpha transmembrane signaling.

Authors:  O R Colamonici; P Domanski; S M Sweitzer; A Larner; R M Buller
Journal:  J Biol Chem       Date:  1995-07-07       Impact factor: 5.157

View more
  17 in total

Review 1.  Viral biocontrol: grand experiments in disease emergence and evolution.

Authors:  Francesca Di Giallonardo; Edward C Holmes
Journal:  Trends Microbiol       Date:  2014-10-31       Impact factor: 17.079

2.  Myxoma virus M064 is a novel member of the poxvirus C7L superfamily of host range factors that controls the kinetics of myxomatosis in European rabbits.

Authors:  Jia Liu; Sonia Wennier; Nissin Moussatche; Mary Reinhard; Richard Condit; Grant McFadden
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

3.  Genetic Variability of Myxoma Virus Genomes.

Authors:  Christoph Braun; Andrea Thürmer; Rolf Daniel; Anne-Kathrin Schultz; Ingo Bulla; Horst Schirrmeier; Dietmar Mayer; Andreas Neubert; Claus-Peter Czerny
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

4.  Punctuated Evolution of Myxoma Virus: Rapid and Disjunct Evolution of a Recent Viral Lineage in Australia.

Authors:  Peter J Kerr; John-Sebastian Eden; Francesca Di Giallonardo; David Peacock; June Liu; Tanja Strive; Andrew F Read; Edward C Holmes
Journal:  J Virol       Date:  2019-04-03       Impact factor: 5.103

5.  Molecular characterisation of virulence graded field isolates of myxoma virus.

Authors:  Kevin P Dalton; Ines Nicieza; Aroa Baragaño; Jose Manuel Martín Alonso; Francisco Parra
Journal:  Virol J       Date:  2010-02-26       Impact factor: 4.099

6.  Comparative analysis of the complete genome sequence of the California MSW strain of myxoma virus reveals potential host adaptations.

Authors:  Peter J Kerr; Matthew B Rogers; Adam Fitch; Jay V Depasse; Isabella M Cattadori; Peter J Hudson; David C Tscharke; Edward C Holmes; Elodie Ghedin
Journal:  J Virol       Date:  2013-08-28       Impact factor: 5.103

7.  Genome scale evolution of myxoma virus reveals host-pathogen adaptation and rapid geographic spread.

Authors:  Peter J Kerr; Matthew B Rogers; Adam Fitch; Jay V Depasse; Isabella M Cattadori; Alan C Twaddle; Peter J Hudson; David C Tscharke; Andrew F Read; Edward C Holmes; Elodie Ghedin
Journal:  J Virol       Date:  2013-09-25       Impact factor: 5.103

Review 8.  Poxviruses and the evolution of host range and virulence.

Authors:  Sherry L Haller; Chen Peng; Grant McFadden; Stefan Rothenburg
Journal:  Infect Genet Evol       Date:  2013-10-24       Impact factor: 3.342

9.  Reverse Engineering Field Isolates of Myxoma Virus Demonstrates that Some Gene Disruptions or Losses of Function Do Not Explain Virulence Changes Observed in the Field.

Authors:  June Liu; Isabella M Cattadori; Derek G Sim; John-Sebastian Eden; Edward C Holmes; Andrew F Read; Peter J Kerr
Journal:  J Virol       Date:  2017-09-27       Impact factor: 5.103

10.  Detection of myxoma viruses encoding a defective M135R gene from clinical cases of myxomatosis; possible implications for the role of the M135R protein as a virulence factor.

Authors:  Graham J Belsham; Charlotta Polacek; Solvej Ø Breum; Lars E Larsen; Anette Bøtner
Journal:  Virol J       Date:  2010-01-16       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.